Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Nov 7, 2017, before the open
10-Q filed Nov 7, 2017, 38 days after period end · 0001104659-17-066472
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $3.92M | $2.22M | $1.03M | $1.10M |
| EPS Diluted | -$3.05 | -$0.29 | -$0.32 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR